Reports for RISPERIDONE
Ingredient
RISPERIDONE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-07-29 | 2022-12-17 | 165677 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2023-07-13 | 2023-08-04 | 198489 |
| APO-RISPERIDONE | 1.0MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223543 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-03-11 | 2017-06-01 | 601 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-05-10 | 2017-06-01 | 9906 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-07-26 | 2017-11-29 | 17319 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2017-12-14 | 2018-05-14 | 32827 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2021-07-16 | 2021-08-31 | 142687 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2022-07-05 | 2022-10-31 | 164083 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2023-07-13 | 2023-08-04 | 198486 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE | 0.25MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16154 |
| MYLAN-RISPERIDONE | 0.50MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16157 |
| MYLAN-RISPERIDONE | 1.0MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16160 |
| MYLAN-RISPERIDONE | 2.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16163 |
| MYLAN-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16166 |
| MYLAN-RISPERIDONE | 4.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16169 |
| RISPERDAL ORAL SOLUTION | 1MG | SOLUTION | To be discontinued | 2023-04-27 | 2023-04-27 | 190894 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2018-09-08 | 2018-09-08 | 60753 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |